10-Year community prevalence and trends of severe asymptomatic hypertension among patients with hypertension in the USA: 2007–2016
Background: Severe asymptomatic hypertension (SAH) is associated with significant health cost, morbidity and mortality. Aim: Establish the nationwide prevalence, trends and associated sociodemographic characteristics of SAH among patients with hypertension in the USA. Methods: We utilized the Nation...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2020-12-01
|
| Series: | International Journal of Cardiology. Hypertension |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2590086220300434 |
| _version_ | 1818556299770593280 |
|---|---|
| author | Muchi Ditah Chobufo Ebad Ur Rahman Fatima Farah Mohamed Suliman Kanaan Mansoor Adee Elhamdani Mehiar El-Hamdani Sudarshan Balla |
| author_facet | Muchi Ditah Chobufo Ebad Ur Rahman Fatima Farah Mohamed Suliman Kanaan Mansoor Adee Elhamdani Mehiar El-Hamdani Sudarshan Balla |
| author_sort | Muchi Ditah Chobufo |
| collection | DOAJ |
| description | Background: Severe asymptomatic hypertension (SAH) is associated with significant health cost, morbidity and mortality. Aim: Establish the nationwide prevalence, trends and associated sociodemographic characteristics of SAH among patients with hypertension in the USA. Methods: We utilized the National Health and Nutrition Examination data collected over five survey cycles (2007–2016). Included were participants aged 20–80 years with self-reported diagnosis of hypertension. SAH was defined as having a mean systolic blood pressure (SBP) ≥180 mmHg and/or mean diastolic blood pressure (DBP) ≥120 mmHg at the time of examination. The Chi square test was used to compare prevalence across different categories. Associations between sociodemographic variables and SAH were assessed using multivariate binary logistic regression. Results: The prevalence of SAH among patients with hypertension is 2.15% (95% CI 1.80–2.56), mainly explained by isolated mean SBP≥180 mmHg (86% of all cases), with no statistically significant change between 2007: 2.66% (95% CI 2.10–3.36) and 2016:2.61% [95% CI 1.73–3.94), p-trend = 0.17. Increasing age (OR 1.07, 95% CI 1.04–1.09), NH Blacks (OR 2.20, 95% CI 1.37–3.54), BMI< 25 (OR 2.52, 95% CI 1.48–4.28), lack of health insurance OR 4.92% (95% CI 2.53–9.54) and never married individuals (OR = 2.59%, 95% CI 1.20–5.60) were more likely to have SAH, comparatively. There was no significant association between duration of hypertension and SAH. Conclusion: The prevalence of SAH in the USA is 2.15% and has been stable over the past decade. Our study underscores the importance of identifying barriers to screening and treatment of hypertension which is a major treatable risk factor for cardiovascular disease. |
| first_indexed | 2024-12-13T23:45:33Z |
| format | Article |
| id | doaj.art-dd6d063c826c40c7945b8176b63f2cab |
| institution | Directory Open Access Journal |
| issn | 2590-0862 |
| language | English |
| last_indexed | 2024-12-13T23:45:33Z |
| publishDate | 2020-12-01 |
| publisher | Elsevier |
| record_format | Article |
| series | International Journal of Cardiology. Hypertension |
| spelling | doaj.art-dd6d063c826c40c7945b8176b63f2cab2022-12-21T23:26:59ZengElsevierInternational Journal of Cardiology. Hypertension2590-08622020-12-01710006610-Year community prevalence and trends of severe asymptomatic hypertension among patients with hypertension in the USA: 2007–2016Muchi Ditah Chobufo0Ebad Ur Rahman1Fatima Farah2Mohamed Suliman3Kanaan Mansoor4Adee Elhamdani5Mehiar El-Hamdani6Sudarshan Balla7Department of Internal Medicine, Interfaith Medical Ctr, Brooklyn, NY, 11213, USADepartment of Internal Medicine, St Mary's Medical Ctr, Huntington, WV, 25701, USADeccan College of Medical Sciences, Hyderabad, IndiaDepartment of Cardiology, Marshall University, Huntington, WV, 25701, USADepartment of Cardiology, Marshall University, Huntington, WV, 25701, USADepartment of Internal Medicine, Allegheny Health Network, Pittsburgh, USADepartment of Cardiology, Marshall University, Huntington, WV, 25701, USADepartment of Cardiology and Cardiothoracic Surgery, West Virginia University, Morgantown, WV, 26505, USA; Corresponding author. Department of Cardiology and Cardiothoracic Surgery, 1 Medical Center Drive West Virginia University, Morgantown, WV, 26508, USA..Background: Severe asymptomatic hypertension (SAH) is associated with significant health cost, morbidity and mortality. Aim: Establish the nationwide prevalence, trends and associated sociodemographic characteristics of SAH among patients with hypertension in the USA. Methods: We utilized the National Health and Nutrition Examination data collected over five survey cycles (2007–2016). Included were participants aged 20–80 years with self-reported diagnosis of hypertension. SAH was defined as having a mean systolic blood pressure (SBP) ≥180 mmHg and/or mean diastolic blood pressure (DBP) ≥120 mmHg at the time of examination. The Chi square test was used to compare prevalence across different categories. Associations between sociodemographic variables and SAH were assessed using multivariate binary logistic regression. Results: The prevalence of SAH among patients with hypertension is 2.15% (95% CI 1.80–2.56), mainly explained by isolated mean SBP≥180 mmHg (86% of all cases), with no statistically significant change between 2007: 2.66% (95% CI 2.10–3.36) and 2016:2.61% [95% CI 1.73–3.94), p-trend = 0.17. Increasing age (OR 1.07, 95% CI 1.04–1.09), NH Blacks (OR 2.20, 95% CI 1.37–3.54), BMI< 25 (OR 2.52, 95% CI 1.48–4.28), lack of health insurance OR 4.92% (95% CI 2.53–9.54) and never married individuals (OR = 2.59%, 95% CI 1.20–5.60) were more likely to have SAH, comparatively. There was no significant association between duration of hypertension and SAH. Conclusion: The prevalence of SAH in the USA is 2.15% and has been stable over the past decade. Our study underscores the importance of identifying barriers to screening and treatment of hypertension which is a major treatable risk factor for cardiovascular disease.http://www.sciencedirect.com/science/article/pii/S2590086220300434HypertensionNHANESPrevalence |
| spellingShingle | Muchi Ditah Chobufo Ebad Ur Rahman Fatima Farah Mohamed Suliman Kanaan Mansoor Adee Elhamdani Mehiar El-Hamdani Sudarshan Balla 10-Year community prevalence and trends of severe asymptomatic hypertension among patients with hypertension in the USA: 2007–2016 International Journal of Cardiology. Hypertension Hypertension NHANES Prevalence |
| title | 10-Year community prevalence and trends of severe asymptomatic hypertension among patients with hypertension in the USA: 2007–2016 |
| title_full | 10-Year community prevalence and trends of severe asymptomatic hypertension among patients with hypertension in the USA: 2007–2016 |
| title_fullStr | 10-Year community prevalence and trends of severe asymptomatic hypertension among patients with hypertension in the USA: 2007–2016 |
| title_full_unstemmed | 10-Year community prevalence and trends of severe asymptomatic hypertension among patients with hypertension in the USA: 2007–2016 |
| title_short | 10-Year community prevalence and trends of severe asymptomatic hypertension among patients with hypertension in the USA: 2007–2016 |
| title_sort | 10 year community prevalence and trends of severe asymptomatic hypertension among patients with hypertension in the usa 2007 2016 |
| topic | Hypertension NHANES Prevalence |
| url | http://www.sciencedirect.com/science/article/pii/S2590086220300434 |
| work_keys_str_mv | AT muchiditahchobufo 10yearcommunityprevalenceandtrendsofsevereasymptomatichypertensionamongpatientswithhypertensionintheusa20072016 AT ebadurrahman 10yearcommunityprevalenceandtrendsofsevereasymptomatichypertensionamongpatientswithhypertensionintheusa20072016 AT fatimafarah 10yearcommunityprevalenceandtrendsofsevereasymptomatichypertensionamongpatientswithhypertensionintheusa20072016 AT mohamedsuliman 10yearcommunityprevalenceandtrendsofsevereasymptomatichypertensionamongpatientswithhypertensionintheusa20072016 AT kanaanmansoor 10yearcommunityprevalenceandtrendsofsevereasymptomatichypertensionamongpatientswithhypertensionintheusa20072016 AT adeeelhamdani 10yearcommunityprevalenceandtrendsofsevereasymptomatichypertensionamongpatientswithhypertensionintheusa20072016 AT mehiarelhamdani 10yearcommunityprevalenceandtrendsofsevereasymptomatichypertensionamongpatientswithhypertensionintheusa20072016 AT sudarshanballa 10yearcommunityprevalenceandtrendsofsevereasymptomatichypertensionamongpatientswithhypertensionintheusa20072016 |